Search Results 1051-1060 of 19344 for hemoglobin

1. A Study To Evaluate Tranexamic Acid (TXA) Versus Placebo To Reduce Perioperative Blood Transfusion In Patients Undergoing Liver Resection - Mayo Clinic

   Severe anemia (hemoglobin (Hgb) levels <90 g/l). Documented arterial or venous thrombosis at screening or in past three months (not including therapeutic ...

2. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

   Hemoglobin >= 8.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min ...

3. Enhancing the Natriuretic Peptide System in HFpEF - Mayo Clinic

   * Stroke within 3 months of screening, or other evidence of significantly compromised CNS perfusion. * Hemoglobin \< 9 g/dl * ALT \> 2 times the upper limit ...

4. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

   Hemoglobin >= 8 g/dL (may be supported). Patients with a known seizure disorder should be stable and should not have experienced a significant increase in ...

5. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

   Hemoglobin < 10 g/dL; or; WBC < 3.0 x 103/mm^3; or; Platelet count < 100,000 ... Hemoglobin A1C > 7.5%, confirmed by repeat. Urine drug screen positive ...

6. Global Trial in APG2575 for Patients With CLL/​SLL - Mayo Clinic

   * Total hemoglobin ≥ 9 g/dL, 5. Adequate renal function * Creatinine clearance must be \> 50 ml/min directly measured with 24hr urine collection or ...

7. A Study to Evaluate the Safety and Effectiveness of CAEL-101 and Plasma Cell Dyscrasia Treatment vs. Placebo and Plasma Cell Dyscrasia Tretment to Treat Patients with Mayo Stage IIIb AL Amyloidosis

   Anemia: hemoglobin value of \> 20 g/L below the lowest limit of normal, or a hemoglobin value \< 100 g/L OR iv. Bone lesions: one or more osteolytic lesion ...

8. A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety - Mayo Clinic

   Hemoglobin < 100 g/L;; NT-proBNP ≥ 500 pg/mL. If one of these criteria is not met based on central laboratory report, a re-test must be performed before ...

9. A Study to Evaluate Infigratinib to Treat Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF 302) - Mayo Clinic

   Hemoglobin 1 week before randomization and hemoglobin remains stable. Have insufficient hepatic and renal function: Total bilirubin > 1.5 × upper limit of ...

10. A Study to Evaluate AntiThrombotic Therapy to Lessen Complications of COVID-19 (Enrolling by Invitation Only) - Mayo Clinic

    Hemoglobin < 80 g/L (to minimize the likelihood of requiring red blood cell transfusion if potential bleeding were to occur). Acute or subacute bacterial ...